BRIEF-Larimar Therapeutics Q1 Net Income USD -29.613 Million

Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc.

LRMR

0.00

May 14 (Reuters) - Larimar Therapeutics Q1 income from operations USD -31.117 million.

  • Q1 operating expenses USD 31.117 million
  • Q1 EPS USD -0.31